These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9274835)

  • 21. Mycophenolate mofetil.
    Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
    Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term benefit of mycophenolate mofetil in renal transplantation.
    Lang P; Pardon A; Audard V
    Transplantation; 2005 Feb; 79(3 Suppl):S47-8. PubMed ID: 15699751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
    J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
    Lederer SR; Friedrich N; Banas B; Welser G; Albert ED; Sitter T
    Clin Transplant; 2005 Apr; 19(2):168-74. PubMed ID: 15740551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil--clinical and experimental experience.
    Pirsch JD; Sollinger HW
    Ther Drug Monit; 1996 Aug; 18(4):357-61. PubMed ID: 8857550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil: a unique immunosuppressive agent.
    Hood KA; Zarembski DG
    Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment.
    Renlund DG; Gopinathan SK; Kfoury AG; Taylor DO
    Clin Transplant; 1996 Feb; 10(1 Pt 2):136-9. PubMed ID: 8680051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mofetil in renal transplantation: results from the U.S. randomized trials.
    Danovitch GM
    Kidney Int Suppl; 1995 Dec; 52():S93-6. PubMed ID: 8587293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective use of mycophenolate mofetil in renal transplant patients in Indian scenario.
    Srivastava A; Singh V; Kumar A; Sharma RK; Gupta A
    Transplant Proc; 2004 Sep; 36(7):2060-4. PubMed ID: 15518746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of severe acute vascular rejection in a renal allograft with mycophenolate mofetil and high dose steroids.
    Lafferty ME; Lang S; McGregor E; Henderson IS; Jones MC
    Scott Med J; 1997 Jun; 42(3):79-80. PubMed ID: 9351121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA
    Curr Opin Cardiol; 1998 Mar; 13(2):117-21. PubMed ID: 9593551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F; Serón D; Morales JM; Cruzado JM; Gil-Vernet S; Pérez JL; Fulladosa X; Andrés A; Grinyó JM
    Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
    Transplantation; 1999 Aug; 68(3):391-6. PubMed ID: 10459543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enteric-coated mycophenolate sodium: therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients.
    Sollinger H
    Transplant Proc; 2004 Mar; 36(2 Suppl):517S-520S. PubMed ID: 15041399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolates in transplantation.
    Sollinger HW
    Clin Transplant; 2004 Oct; 18(5):485-92. PubMed ID: 15344948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systematic review.
    Wang K; Zhang H; Li Y; Wei Q; Li H; Yang Y; Lu Y
    Transplant Proc; 2004 Sep; 36(7):2071-2. PubMed ID: 15518749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.